See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Regeneron Pharmaceuticals, Inc. (REGN) - free report >>
Gilead Sciences, Inc. (GILD) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Regeneron Pharmaceuticals, Inc. (REGN) - free report >>
Gilead Sciences, Inc. (GILD) - free report >>
Top 5 Drug Stocks To Stop The Coronavirus Pandemic
Coming up with a vaccine or treatment for this pandemic is crucial for human life to go back to normality. The number of cases is growing exponentially in every corner of the globe, closing in on half a million. The world is looking to biotech companies for the cure.
Gilead Sciences’ (GILD - Free Report) preliminary drug, remdesivir, is seen as one of the more promising coronavirus treatments. Remdisivir received orphan drug status as of Monday by the FDA.
Regeneron (REGN - Free Report) and Sanofi (SNY - Free Report) are amid clinical trials on coronavirus patients with their drug, Kevzara. Kevzara was initially purposed for arthritis treatment but could prove as an effective treatment for COVID-19.
Moderna (MRNA - Free Report) CEO says it could have a vaccine for health care professionals by this fall. Inovio Pharmaceuticals (INO - Free Report) is also in the hunt for a coronavirus vaccine.
These firms are working tirelessly to get their vaccines and treatments to the people. It is only a matter of time before this virus anxiety is a thing of the past.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>